Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Cidara Thera (CDTX)
Cidara Thera (CDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,030
  • Shares Outstanding, K 90,434
  • Annual Sales, $ 64,290 K
  • Annual Income, $ -29,800 K
  • 60-Month Beta 1.13
  • Price/Sales 1.07
  • Price/Cash Flow N/A
  • Price/Book 8.76
Trade CDTX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.39
  • Most Recent Earnings -0.09 on 11/02/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 234.78% ( -156.65%)
  • Historical Volatility 54.57%
  • IV Percentile 42%
  • IV Rank 20.48%
  • IV High 972.49% on 12/29/22
  • IV Low 44.77% on 11/15/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 53
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 2,732
  • Open Int (30-Day) 2,407

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +57.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5930 +21.82%
on 11/17/23
0.8400 -14.00%
on 11/16/23
-0.0576 (-7.38%)
since 11/08/23
3-Month
0.5930 +21.82%
on 11/17/23
1.2200 -40.79%
on 09/20/23
-0.2710 (-27.28%)
since 09/08/23
52-Week
0.4650 +55.35%
on 12/20/22
2.1000 -65.60%
on 03/22/23
+0.2397 (+49.66%)
since 12/08/22

Most Recent Stories

More News
Cidara Therapeutics: Q3 Earnings Snapshot

Cidara Therapeutics: Q3 Earnings Snapshot

CDTX : 0.7440 (+0.38%)
3 Biotech Gems to Keep on Your Radar

The biotech industry's expansion seems to stem from advancements in drug development, cutting-edge technology, and substantial government backing. Given these factors, prominent biotech stocks Surrozen...

CDTX : 0.7440 (+0.38%)
HRMY : 31.25 (+0.64%)
SRZN : 0.5400 (-0.15%)
3 Biotech Stocks Smart Money Is After

Biotech companies such as Biogen (BIIB), Cidara Therapeutics (CDTX), and Theratechnologies (THTX) with the interest of institutional investors could be worth investing in now. Continue reading… ...

BIIB : 239.49 (+0.15%)
CDTX : 0.7440 (+0.38%)
THTX : 1.6100 (+1.58%)
Cidara Therapeutics: Q2 Earnings Snapshot

Cidara Therapeutics: Q2 Earnings Snapshot

CDTX : 0.7440 (+0.38%)
Are These Biotech Stocks a Buy or Sell for August: Bionano Genomics (BNGO) vs. Cidara Therapeutics (CDTX)?

Underpinned by undeniable growth trends of an aging population, breakthrough therapies, and the inelastic demand for healthcare products and medicines, the biotech industry is expected to perform well...

BNGO : 1.4800 (-2.63%)
CDTX : 0.7440 (+0.38%)
3 Value Stocks With Great Returns

April’s robust labor market and persistently high inflation could strengthen the likelihood of interest rates remaining elevated for an extended period. So, fundamentally strong value stocks CIRCOR International...

CDTX : 0.7440 (+0.38%)
CIR : 56.00 (+5.16%)
CWCO : 36.18 (-0.63%)
4 Hyper-Growth Stocks That Could Soar

Coupled with the macroeconomic headwinds, the U.S. debt default crisis and consequent recessionary fears have triggered market volatility. Against this backdrop, quality growth stocks Boston Scientific...

BSX : 54.95 (-0.15%)
CAH : 106.78 (+0.38%)
CDTX : 0.7440 (+0.38%)
GEOS : 11.47 (-3.78%)
Cidara Therapeutics: Q1 Earnings Snapshot

Cidara Therapeutics: Q1 Earnings Snapshot

CDTX : 0.7440 (+0.38%)
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates

Merus N.V. (MRUS) delivered earnings and revenue surprises of 19.63% and 27.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

MRUS : 24.05 (-2.87%)
CDTX : 0.7440 (+0.38%)
Are Options Traders Betting on a Big Move in Cidara (CDTX) Stock?

Investors need to pay close attention to Cidara (CDTX) stock based on the movements in the options market lately.

CDTX : 0.7440 (+0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company...

See More

Key Turning Points

3rd Resistance Point 0.8680
2nd Resistance Point 0.8390
1st Resistance Point 0.7901
Last Price 0.7440
1st Support Level 0.7122
2nd Support Level 0.6832
3rd Support Level 0.6343

See More

52-Week High 2.1000
Fibonacci 61.8% 1.4754
Fibonacci 50% 1.2825
Fibonacci 38.2% 1.0896
Last Price 0.7440
52-Week Low 0.4650

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar